Exagen Inc.
NASDAQ: XGN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- John Aballi
- Employees
- 209
- Headquarters
- Vista, United States
- IPO year
- 2019
- Market cap
- $109.2M
- Website
- https://www.exagen.com
Loading XGN…
Loading profile data…Frequently asked questions about XGN
What does Exagen Inc. (XGN) do?
Exagen Inc. develops and commercializes diagnostic testing solutions, leveraging its proprietary cell-bound complement activation products (CB-CAPs) technology under the AVISE brand throughout the United States. The company's mission is to equip rheumatologists with advanced tools for the precise diagnosis, prognosis, and ongoing management of a...
Where does XGN trade?
Exagen Inc. (XGN) trades on the NASDAQ Global Market.
What sector is XGN in?
Exagen Inc. (XGN) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Exagen Inc.?
John Aballi is the chief executive officer of Exagen Inc. (XGN).
Where is Exagen Inc. headquartered?
Exagen Inc. is headquartered in United States.
Does XGN pay a dividend?
Exagen Inc. (XGN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did XGN go public?
Exagen Inc. (XGN) completed its initial public offering in 2019.